XML 97 R83.htm IDEA: XBRL DOCUMENT v3.19.2
Pro Forma Financial Statements (Details 2)
12 Months Ended
Dec. 31, 2018
USD ($)
$ / shares
shares
BioLite [Member]  
Outstanding shares as of December 31, 2018 41,207,444
Exchange of each BioLite share of common stock outstanding as of December 31, 2018, for 1.82 shares of ABVC common stock | $ / shares $ 1.82
ABVC common stock to be issued to BioLite as a result of the Merger 74,997,548
Par value $0.001 per share of ABVC | $ $ 74,998
BioKey [Member]  
Outstanding shares as of December 31, 2018 7,428,134
Exchange of each BioLite share of common stock outstanding as of December 31, 2018, for 1.82 shares of ABVC common stock | $ / shares $ 1
ABVC common stock to be issued to BioKey as a result of the Merger 7,428,134
Par value $0.001 per share of ABVC | $ $ 7,428